52.00
price down icon4.25%   -2.31
 
loading
前日終値:
$54.31
開ける:
$54.91
24時間の取引高:
410.84K
Relative Volume:
1.12
時価総額:
$2.92B
収益:
$226.84M
当期純損益:
$3.55M
株価収益率:
742.86
EPS:
0.07
ネットキャッシュフロー:
$-12.02M
1週間 パフォーマンス:
-8.92%
1か月 パフォーマンス:
-12.69%
6か月 パフォーマンス:
+8.13%
1年 パフォーマンス:
+8.04%
1日の値動き範囲:
Value
$51.84
$54.91
1週間の範囲:
Value
$51.84
$58.77
52週間の値動き範囲:
Value
$39.12
$63.00

Vericel Corp Stock (VCEL) Company Profile

Name
名前
Vericel Corp
Name
セクター
Healthcare (1169)
Name
電話
(734) 930-5555
Name
住所
64 SIDNEY ST., CAMBRIDGE, MA
Name
職員
0
Name
Twitter
@VericelCorp
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
VCEL's Discussions on Twitter

VCEL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
VCEL
Vericel Corp
52.00 2.92B 226.84M 3.55M -12.02M 0.07
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Vericel Corp Stock (VCEL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-09 開始されました Canaccord Genuity Buy
2024-06-20 開始されました TD Cowen Buy
2024-01-25 アップグレード Truist Hold → Buy
2023-08-08 アップグレード BTIG Research Neutral → Buy
2022-11-10 ダウングレード BTIG Research Buy → Neutral
2022-11-09 ダウングレード Truist Buy → Hold
2022-10-14 再開されました Stephens Overweight
2021-01-11 ダウングレード Oppenheimer Outperform → Perform
2020-12-18 開始されました Stephens Overweight
2020-09-17 開始されました Truist Buy
2019-10-09 開始されました H.C. Wainwright Buy
2019-02-28 ダウングレード Needham Buy → Hold
2018-08-08 繰り返されました Needham Buy
2018-07-16 アップグレード Ladenburg Thalmann Neutral → Buy
2018-04-04 開始されました Leerink Partners Outperform
2018-03-06 ダウングレード Ladenburg Thalmann Buy → Neutral
2018-03-06 繰り返されました Needham Buy
2018-03-05 繰り返されました BTIG Research Buy
2017-06-21 開始されました BTIG Research Buy
2017-03-13 繰り返されました Needham Buy
2016-12-22 開始されました Piper Jaffray Overweight
2016-11-09 繰り返されました Needham Buy
2016-04-05 ダウングレード BofA/Merrill Buy → Neutral
2016-03-11 アップグレード Needham Hold → Buy
すべてを表示

Vericel Corp (VCEL) 最新ニュース

pulisher
Feb 20, 2025

New York State Common Retirement Fund Has $46.94 Million Stake in Vericel Co. (NASDAQ:VCEL) - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Kornitzer Capital Management Inc. KS Makes New Investment in Vericel Co. (NASDAQ:VCEL) - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

TimesSquare Capital Management LLC Has $34.71 Million Stock Holdings in Vericel Co. (NASDAQ:VCEL) - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Vericel Co. (NASDAQ:VCEL) Shares Sold by Legato Capital Management LLC - MarketBeat

Feb 19, 2025
pulisher
Feb 18, 2025

Allspring Global Investments Holdings LLC Cuts Stock Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World

Feb 18, 2025
pulisher
Feb 17, 2025

Vericel Co. (NASDAQ:VCEL) Shares Purchased by Congress Asset Management Co. - MarketBeat

Feb 17, 2025
pulisher
Feb 15, 2025

Vericel director Kevin McLaughlin sells shares worth $388,250 - MSN

Feb 15, 2025
pulisher
Feb 15, 2025

Yousif Capital Management LLC Trims Stock Position in Vericel Co. (NASDAQ:VCEL) - Defense World

Feb 15, 2025
pulisher
Feb 11, 2025

Jonathan Siegal Sells 1,092 Shares of Vericel Co. (NASDAQ:VCEL) Stock - MarketBeat

Feb 11, 2025
pulisher
Feb 11, 2025

Vericel Co. (NASDAQ:VCEL) Director Sells $156,250.00 in Stock - MarketBeat

Feb 11, 2025
pulisher
Feb 09, 2025

Vericel (NASDAQ:VCEL) Sets New 52-Week HighHere's Why - MarketBeat

Feb 09, 2025
pulisher
Feb 08, 2025

Vericel's principal accounting officer sells $67,693 in stock - MSN

Feb 08, 2025
pulisher
Feb 08, 2025

Vericel's principal accounting officer sells $67,693 in stock By Investing.com - Investing.com Australia

Feb 08, 2025
pulisher
Feb 08, 2025

Vericel director Robert Zerbe sells $156,250 in stock - Investing.com India

Feb 08, 2025
pulisher
Feb 07, 2025

Vericel Co. (NASDAQ:VCEL) Insider Jonathan Siegal Sells 1,092 Shares - Armenian Reporter

Feb 07, 2025
pulisher
Feb 07, 2025

Vericel director Robert Zerbe sells $156,250 in stock By Investing.com - Investing.com Canada

Feb 07, 2025
pulisher
Feb 06, 2025

Conestoga Capital Advisors LLC Sells 6,300 Shares of Vericel Co. (NASDAQ:VCEL) - MarketBeat

Feb 06, 2025
pulisher
Feb 06, 2025

Canaccord Genuity Group Increases Vericel (NASDAQ:VCEL) Price Target to $67.00 - MarketBeat

Feb 06, 2025
pulisher
Feb 06, 2025

Vericel Corp [NASDAQ: VCEL] Sees Increase in Stock Value - Knox Daily

Feb 06, 2025
pulisher
Feb 05, 2025

Vericel (NASDAQ:VCEL) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World

Feb 05, 2025
pulisher
Feb 05, 2025

Brokerages Set Vericel Co. (NASDAQ:VCEL) PT at $62.14 - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

Vericel Co. (NASDAQ:VCEL) Receives $62.14 Average Price Target from Analysts - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

SG Americas Securities LLC Trims Stock Position in Vericel Co. (NASDAQ:VCEL) - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

What 7 Analyst Ratings Have To Say About Vericel - Benzinga

Feb 03, 2025
pulisher
Feb 03, 2025

Canaccord raises Vericel stock target to $67, maintains buy rating - Investing.com

Feb 03, 2025
pulisher
Feb 02, 2025

Vericel Co. (NASDAQ:VCEL) Insider Sells $242,256.92 in Stock - MarketBeat

Feb 02, 2025
pulisher
Feb 01, 2025

SG Americas Securities LLC Lowers Stock Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World

Feb 01, 2025
pulisher
Jan 31, 2025

Vericel (NASDAQ:VCEL) Sets New 1-Year HighStill a Buy? - MarketBeat

Jan 31, 2025
pulisher
Jan 28, 2025

VCEL Stock Touches 52-Week High at $61.5 Amidst Strong Growth - MSN

Jan 28, 2025
pulisher
Jan 26, 2025

Park Avenue Securities LLC Takes $280,000 Position in Vericel Co. (NASDAQ:VCEL) - MarketBeat

Jan 26, 2025
pulisher
Jan 26, 2025

Park Avenue Securities LLC Buys Shares of 5,099 Vericel Co. (NASDAQ:VCEL) - Defense World

Jan 26, 2025
pulisher
Jan 25, 2025

Vericel (NASDAQ:VCEL) Stock Passes Above 200 Day Moving Average – Here’s What Happened - Defense World

Jan 25, 2025
pulisher
Jan 25, 2025

Vericel (NASDAQ:VCEL) Stock Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Jan 25, 2025
pulisher
Jan 21, 2025

Burns Pipeline 2024: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | MediWound, Kaken Pharma, Kerecis, Medline, Mallinckrodt Pharma, Avita Medical, Vericel Corp - The Globe and Mail

Jan 21, 2025
pulisher
Jan 17, 2025

Equities Analysts Set Expectations for Vericel Q3 Earnings - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Vericel (NASDAQ:VCEL) Earns “Overweight” Rating from Stephens - Defense World

Jan 17, 2025
pulisher
Jan 17, 2025

FY2024 EPS Estimates for Vericel Reduced by HC Wainwright - Defense World

Jan 17, 2025
pulisher
Jan 16, 2025

FY2024 Earnings Estimate for Vericel Issued By HC Wainwright - MarketBeat

Jan 16, 2025
pulisher
Jan 15, 2025

Vericel expects 2024 net revenue in range of $237 to $237.5 million - MSN

Jan 15, 2025
pulisher
Jan 15, 2025

Analyst supports Vericel stock outlook citing MACI Arthro synergies and expansion plans - Investing.com

Jan 15, 2025
pulisher
Jan 15, 2025

Vericel (NASDAQ:VCEL) Shares Gap DownShould You Sell? - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

Vericel (NASDAQ:VCEL) Receives "Overweight" Rating from Stephens - MarketBeat

Jan 15, 2025

Vericel Corp (VCEL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):